No title
Breast cancer is the most common type of cancer among the female population in Sweden. Genomic mutations of patients are a very important source of information for treatment choice and outcome prediction. RNA-sequencing (RNA-seq) has become the de facto standard for expression profiling and can also be used for the detection of genomic variants. However, RNA-seq-based variant detection suffers fro
